Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NIPAL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-05 |
mRNA | TMEM189 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
mRNA | ITGB3 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | UNC13B | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | VCX | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | CCDC151 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | CYSRT1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | TMEM106B | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | SGTA | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | PPP2R5D | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |